N6-Methyladenine-Related Signature for Immune Microenvironment and Response to Immunotherapy in Hepatocellular Carcinoma

N6-Methyladenine-Related Signature for Immune Microenvironment and Response to Immunotherapy in Hepatocellular Carcinoma

Shao-hua Ren,1,2 Ya-fei Qin,1,2 Hong Qin,1,2 Hong-da Wang,1,2 Guang-ming Li,1,2 Yang-lin Zhu,1,2 Cheng-lu Sun,1,2 Bo Shao,1,2 Jing-yi Zhang,1,2 Jing-peng Hao,3 Hao Wang1,2 1Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China; 2Tianjin Gener...

Full description

Bibliographic Details
Main Authors:	Ren SH, Qin YF, Qin H, Wang HD, Li GM, Zhu YL, Sun CL, Shao B, Zhang JY, Hao JP, Wang H
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-03-01
Series:	International Journal of General Medicine
Subjects:	hepatocellular carcinoma n6-methyladenine tumor immune microenvironment immunotherapy drug sensitivity
Online Access:	https://www.dovepress.com/n6-methyladenine-related-signature-for-immune-microenvironment-and-res-peer-reviewed-fulltext-article-IJGM

Similar Items

N6-methyladenine regulator-mediated RNA methylation modification patterns in immune microenvironment regulation of osteoarthritis
by: Yong Gu, et al.
Published: (2023-01-01)

Identification of DNA N6-methyladenine sites by integration of sequence features
by: Hao-Tian Wang, et al.
Published: (2020-02-01)

DNA N6-Methyladenine Modification in Eukaryotic Genome
by: Hao Li, et al.
Published: (2022-06-01)

Effects of autophagy inhibitor 3-methyladenine on a diabetic mice model
by: Hai-Wen Ren, et al.
Published: (2023-09-01)

3-Methyladenine prevents energy stress-induced necrotic death of melanoma cells through autophagy-independent mechanisms
by: Milica Kosic, et al.
Published: (2021-09-01)

Molecular characterization of Plasmodium falciparum DNA-3-methyladenine glycosylase
by: Nattapon Pinthong, et al.
Published: (2020-08-01)

Characteristics and functions of DNA N(6)-methyladenine in embryonic chicken muscle development
by: Maosen Yang, et al.
Published: (2023-05-01)

Pretreatment with 3-methyladenine ameliorated Pseudomonas aeruginosa-induced acute pneumonia by inhibiting cell death of neutrophils in a mouse infection model
by: Lei Yue, et al.
Published: (2023-03-01)

N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity
by: Sara B. Fernandes, et al.
Published: (2021-05-01)

Guanylate‐binding proteins signature predicts favorable prognosis, immune‐hot microenvironment, and immunotherapy response in hepatocellular carcinoma
by: Yumei Ning, et al.
Published: (2023-08-01)

Hollow MIL-125 Nanoparticles Loading Doxorubicin Prodrug and 3-Methyladenine for Reversal of Tumor Multidrug Resistance
by: Qingfeng Guo, et al.
Published: (2023-11-01)

MASQC: Next Generation Sequencing Assists Third Generation Sequencing for Quality Control in N6-Methyladenine DNA Identification
by: Siqian Yang, et al.
Published: (2020-03-01)

Histological evaluation of the effects of rapamycin and 3-methyladenine on cisplatin-induced epididymal injury in rats
by: Tayfun Ceylan, et al.
Published: (2021-09-01)

Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
by: Feng H, et al.
Published: (2022-10-01)

Ginsenoside Re prevents 3-methyladenine-induced catagen phase acceleration by regulating Wnt/β-catenin signaling in human dermal papilla cells
by: Gyusang Jeong, et al.
Published: (2023-05-01)

Femtomolar and locus-specific detection of N6-methyladenine in DNA by integrating double-hindered replication and nucleic acid-functionalized MB@Zr-MOF
by: Qingyuan Zheng, et al.
Published: (2021-12-01)

A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
by: Baohui Zhang, et al.
Published: (2020-09-01)

Cell Death Triggered by the Autophagy Inhibitory Drug 3-Methyladenine in Growing Conditions Proceeds With DNA Damage
by: Javier Chicote, et al.
Published: (2020-10-01)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
by: Yuanxin Shi, et al.
Published: (2023-05-01)

Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma
by: Jun Tang, et al.
Published: (2024-01-01)

A Bioinformatics Tool for the Prediction of DNA N6-Methyladenine Modifications Based on Feature Fusion and Optimization Protocol
by: Jianhua Cai, et al.
Published: (2020-06-01)

A Deep Learning Model for Predicting DNA N6-Methyladenine (6mA) Sites in Eukaryotes
by: Lokuthota Hewage Roland, et al.
Published: (2020-01-01)

Thermal Stability Changes in Telomeric G-Quadruplex Structures Due to <i>N</i><sup>6</sup>-Methyladenine Modification
by: Ryohei Wada, et al.
Published: (2021-02-01)

A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma
by: Xinjiang Ding, et al.
Published: (2023-03-01)

Biological networks in gestational diabetes mellitus: insights into the mechanism of crosstalk between long non-coding RNA and N6-methyladenine modification
by: Runyu Du, et al.
Published: (2022-05-01)

Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma
by: Gongjun Wang, et al.
Published: (2022-04-01)

The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
by: Zhang Guizhen, et al.
Published: (2022-08-01)

Identifying RNA N6-Methyladenine Sites in Three Species Based on a Markov Model
by: Cong Pian, et al.
Published: (2021-03-01)

Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
by: Ming Zhao, et al.
Published: (2023-05-01)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
by: Changjing Huang, et al.
Published: (2021-11-01)

Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
by: Chen Chen, et al.
Published: (2023-02-01)

Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect
by: Tian H, et al.
Published: (2020-07-01)

Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
by: Li Z, et al.
Published: (2023-11-01)

The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
by: Bufu Tang, et al.
Published: (2020-10-01)

SoftVoting6mA: An improved ensemble-based method for predicting DNA N6-methyladenine sites in cross-species genomes
by: Zhaoting Yin, et al.
Published: (2024-02-01)

M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy
by: Kun Zhao, et al.
Published: (2022-11-01)

Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
by: Qin Wu, et al.
Published: (2019-05-01)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
by: Yuan Yang, et al.
Published: (2021-06-01)

Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
by: Yanlong Shi, et al.
Published: (2022-12-01)

Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications
by: Xie C, et al.
Published: (2024-01-01)